Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors
摘要:
The iterative process for the discovery of a series of pyrazinone mono-amides as potent, selective and reversible non-peptide caspase-3 inhibitors (e.g., M826 and M867) is reported. These compounds display potent anti apoptotic activities in a number of cell based systems in vitro as well as in several animal models in vivo. (C) 2004 Elsevier Ltd. All rights reserved.
Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors
作者:Yongxin Han、André Giroux、John Colucci、Christopher I. Bayly、Daniel J. Mckay、Sophie Roy、Steve Xanthoudakis、John Vaillancourt、Dita M. Rasper、John Tam、Paul Tawa、Donald W. Nicholson、Robert J. Zamboni
DOI:10.1016/j.bmcl.2004.12.006
日期:2005.2
The iterative process for the discovery of a series of pyrazinone mono-amides as potent, selective and reversible non-peptide caspase-3 inhibitors (e.g., M826 and M867) is reported. These compounds display potent anti apoptotic activities in a number of cell based systems in vitro as well as in several animal models in vivo. (C) 2004 Elsevier Ltd. All rights reserved.
Solid-phase analogue synthesis of caspase-3 inhibitors via palladium-catalyzed amination of 3-bromopyrazinones
作者:Elise Isabel、Renee Aspiotis、W. Cameron Black、John Colucci、Réjean Fortin、André Giroux、Erich L. Grimm、Yongxin Han、Christophe Mellon、Donald W. Nicholson、Dita M. Rasper、Johanne Renaud、Sophie Roy、John Tam、Paul Tawa、John P. Vaillancourt、Steven Xanthoudakis、Robert J. Zamboni
DOI:10.1016/j.bmcl.2006.12.110
日期:2007.3
protease that mediates apoptotic cell death. Its inhibition may have an important impact on the treatment of several degenerative diseases. Here we report the synthesis of reversible inhibitors via a solid-support palladium-catalyzedamination of 3-bromopyrazinones and the discovery of a pan-caspase reversible inhibitor.